Tong Shu, Hong Zheng, Kui Jiang, Fang Liu, Hongruo Liu, Lu lu Yao, Ye Zhao, Ying Ma, Yan Zhang, Guihua Shen, Linlin Ma. "Preliminary analysis of disitamab vedotin combined therapy for HER2-expressing platinum-sensitive recurrent ovarian/peritoneal/fallopian tube cancer (Diversity study): A single-arm, multicenter phase II trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.5564